Cargando…

Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review

Genetic factors are involved in the development, progression, and severity of NAFLD. Polymorphisms in genes regulating liver functions may increase liver susceptibility to NAFLD. Therefore, we conducted this literature study to present recent findings on NAFLD-associated polymorphisms from published...

Descripción completa

Detalles Bibliográficos
Autores principales:	Astarini, Fajar Dwi, Ratnasari, Neneng, Wasityastuti, Widya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pasteur Institute of Iran 2022
Materias:	Full Length
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432469/ https://www.ncbi.nlm.nih.gov/pubmed/36000237 http://dx.doi.org/10.52547/ibj.3647

Ejemplares similares

Mothers’ knowledge of breastfeeding and infant feeding types affect acute respiratory infections
por: JANSEN, SUSIANA, et al.
Publicado: (2020)

Effects of Yacon on Colonic IFN-γ and Goblet Cells of the 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis Mouse Model
por: Umizah, Larasti Putri, et al.
Publicado: (2020)

“Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study”
por: Mardian, Yan, et al.
Publicado: (2019)

Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2020)

Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study
por: Mardian, Yan, et al.
Publicado: (2017)

Effects of low and moderate treadmill exercise on liver of d‐galactose‐exposed aging rat model
por: Wasityastuti, Widya, et al.
Publicado: (2019)

Update of liver fibrosis and steatosis with transient elastography (Fibroscan)
por: Wong, Grace Lai-Hung
Publicado: (2013)

Melatonin Pretreatment Enhances the Homing of Bone Marrow-derived Mesenchymal Stem Cells Following Transplantation in a Rat Model of Liver Fibrosis
por: Mortezaee, Keywan, et al.
Publicado: (2016)

SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review
por: Dwinata, Michael, et al.
Publicado: (2020)

Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
por: Ayoub, Fares, et al.
Publicado: (2018)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2022)

Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study
por: Ciećko-Michalska, Irena, et al.
Publicado: (2018)

Improvement of Liver Cell Therapy in Rats by Dietary Stearic Acid
por: Goradel, Nasser Hashemi, et al.
Publicado: (2016)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Protective Effects of Royal Jelly on Oxymetholone- Induced Liver Injury in Mice
por: Nejati, Vahid, et al.
Publicado: (2016)

Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease
por: Xiang, Liping, et al.
Publicado: (2021)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Liver-specific Mettl3 ablation delays liver regeneration in mice
por: Meng, Jiaxiang, et al.
Publicado: (2020)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
por: Huang, Yan, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
por: Tuong, Tran Thi Khanh, et al.
Publicado: (2020)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Direct production of fatty alcohols from glucose using engineered strains of Yarrowia lipolytica
por: Cordova, Lauren T., et al.
Publicado: (2019)

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence
por: Melton, Phillip E., et al.
Publicado: (2023)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Nogami, Asako, et al.
Publicado: (2023)

Influence of Deuterium-Depleted Water on the Isotope D/H Composition of Liver Tissue and Morphological Development of Rats at Different Periods of Ontogenesis
por: Alexandrovich Basov, Alexandr, et al.
Publicado: (2019)

Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population
por: Ratnasari, Neneng, et al.
Publicado: (2017)

Pathogenesis of Alcoholic Fatty Liver a Narrative Review
por: Seitz, Helmut K., et al.
Publicado: (2023)

Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes
por: Xie, Yilian, et al.
Publicado: (2022)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
por: Safari, Zahra, et al.
Publicado: (2023)

Engineered human liver based on pullulan-dextran hydrogel promotes mice survival after liver failure
por: Le Guilcher, Camille, et al.
Publicado: (2023)

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
por: Nadinskaia, Maria, et al.
Publicado: (2021)

Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis
por: Mohseni, Marzieh, et al.
Publicado: (2016)

Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models
por: Wang, Xiao-Xiao, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
por: Ferro, Yvelise, et al.
Publicado: (2022)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rin10grgp2rd37ca48aqs2ps6m